News

Scientists may have found a new tool for studying—and maybe even treating—Type 2 diabetes, the form of diabetes considered responsible for close to 95 percent of cases in the United States.

Two immune system molecules may be key to the development of drug resistance in estrogen-driven breast cancers.

The new method involves a class of pharmaceuticals known as antibody-drug conjugates (ADCs), which include some of the most promising next-generation antibody therapeutics for cancer.

Next, the researchers plan to further develop their molecule-screening strategy into a platform to test molecules against any form of RNA defect-related disease.

"This work at the molecular level has a real potential to benefit patients."

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have discovered how a protein called α2δ4 establishes proper vision.

Chemists at Scripps Research have devised a versatile molecule-building tool for creating new drugs and other chemical products.

"Given the great clinical demand for MRI for patients with a standard pacemaker or defibrillator, we wanted to determine the risk."

Results from a new Phase 3 study conducted by the Celgene Corporation demonstrate that ozanimod, a drug candidate originally discovered and optimized at Scripps Research, can reduce the frequency of multiple sclerosis relapse.

Scripps Research, one of the world's largest, private, non-profit research organizations, today announced the appointment of nine new members to its Board of Directors.

Is there a way to get metabolism to ramp up—even when it’s not cold out?

"At Scripps Florida we not only do great science, but we have even greater opportunities to collaborate on projects like this."

A Scripps Research team has described the role of two important molecules in the brain that work together to trigger intense anxiety.

"This method essentially mimics the ability of the enzymes in our cells to turn simple organic molecules into chiral molecules."

A new study led by scientists at Scripps Research is giving researchers a first look at the early stages of brain development in patients with Fragile X syndrome.

Biologists at The Scripps Research Institute (TSRI) have identified a brain hormone that appears to trigger fat burning in the gut.

The co-principal investigators of the three-year project are TSRI Professor William R. Roush and Associate Professor Derek Duckett.

Life’s genetic code has only ever contained four natural bases. Until now.

"These results also suggest new insights into the neurocircuitry of heroin addiction."

A team led by scientists at Scripps Research has developed a versatile new method that should enhance the discovery of new drugs and the study of proteins.

The Scripps Research Institute (TSRI), a leading non-profit biomedical research institute, today announced a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) to pioneer new DNA-encoded library (DEL) technology.

Calibr, a corporate affiliate of The Scripps Research Institute, has announced a strategic research collaboration with Intarcia Therapeutics, Inc.

Biologists on the Florida campus of Scripps Research have discovered a new mechanism that likely underlies how we feel force or touch.